Country: United States
Language: English
Source: NLM (National Library of Medicine)
CEVIMELINE HYDROCHLORIDE (UNII: P81Q6V85NP) (CEVIMELINE - UNII:K9V0CDQ56E)
Novel Laboratories, Inc.
CEVIMELINE HYDROCHLORIDE
CEVIMELINE HYDROCHLORIDE ANHYDROUS 30 mg
ORAL
PRESCRIPTION DRUG
Cevimeline is indicated for the treatment of symptoms of dry mouth in patients with SjÖgren's Syndrome. Cevimeline is contraindicated in patients with uncontrolled asthma, known hypersensitivity to cevimeline, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle-closure) glaucoma.
Cevimeline Hydrochloride Capsules are available as hard gelatin capsule with tan opaque cap and tan opaque body imprinted with "NL 999" on the cap and "30 mg" on the body with black ink, filled with white to off white granular powder. It is supplied in: Child-resistant bottles of 30 Capsules (NDC 40032-999-03) Child-resistant bottles of 100 Capsules (NDC 40032-999-01) Bottles of 500 Capsules (NDC 40032-999-05) Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Dispense in a tight, light resistant container as defined in the USP/NF. Rx Only Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Iss. 02/2016 PI9990000101
Abbreviated New Drug Application
CEVIMELINE HYDROCHLORIDE- CEVIMELINE HYDROCHLORIDE CAPSULE NOVEL LABORATORIES, INC. ---------- CEVIMELINE HYDROCHLORIDE CAPSULES DESCRIPTION Cevimeline is cis-2'-methylspiro {1-azabicyclo [2.2.2] octane-3, 5'-[1,3] oxathiolane} hydrochloride, hydrate (2:1). Its empirical formula is C H NOS.HCl.1/2 H O, and its structural formula is: Cevimeline has a molecular weight of 244.79. It is a white to off white crystalline powder with a melting point range of 201 to 203°C. It is freely soluble in alcohol and chloroform, very soluble in water, and virtually insoluble in ether. The pH of a 1% solution ranges from 4.6 to 5.6. Inactive ingredients include lactose monohydrate, hydroxypropyl cellulose, and magnesium stearate; a hard gelatin capsule which contains D&C Yellow #10, FD&C Red #40, FD&C Yellow #6, titanium dioxide and gelatin; and an imprinting ink which contains shellac, iron oxide black, isopropyl alcohol, butyl alcohol, propylene glycol and ammonium hydroxide. CLINICAL PHARMACOLOGY PHARMACODYNAMICS Cevimeline is a cholinergic agonist which binds to muscarinic receptors. Muscarinic agonists in sufficient dosage can increase secretion of exocrine glands, such as salivary and sweat glands and increase tone of the smooth muscle in the gastrointestinal and urinary tracts. PHARMACOKINETICS Absorption: After administration of a single 30 mg capsule, cevimeline was rapidly absorbed with a mean time to peak concentration of 1.5 to 2 hours. No accumulation of active drug or its metabolites was observed following multiple dose administration. When administered with food, there is a decrease in the rate of absorption, with a fasting T of 1.53 hours and a T of 2.86 hours after a meal; the peak concentration is reduced by 17.3%. Single oral doses across the clinical dose range are dose proportional. Distribution: Cevimeline has a volume of distribution of approximately 6L/kg and is <20% bound to human plasma proteins. This suggests that cevimeline is extensively bound to tissues; however, the specific binding sites are unknow Read the complete document